fda tirzepatide compounding warning 2024 2025 Compounded versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said February 17, 2026: Pennsylvania compounding

The right call for atrophic acne scars, stretch marks, or deeper structural concerns that at-home depth cannot reach

The European regulator first launched its investigation into the potential suicidality risk associated with the medications in July 2023

In North Carolina, where 70% of people struggle with being overweight or obese, officials opted to begin covering the drugs for weight loss last year

They work by making you feel full longer, slowing down digestion, and helping your body use insulin more effectively, which can lead to weight loss

Semaglutide (Ozempic) is FDA-approved for specific indications only

Asking questions and expressing any concerns about potential risks can help ensure a better outcome